Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression [Phase 1, Phase 2]
A2 Biotherapeutics is evaluating A2B530, a logic-gated CAR T therapy, in Phase 1/2 trials for CEA-expressing solid tumors that have lost HLA…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients [Phase 1, Phase 2]
First-in-human Phase 1/2 trial of an autologous dendritic cell vaccine targeting Wilms' tumor protein 1 (WT1) with interleukin-15 trans-pres…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer
This clinical trial outlines a personalized management pathway for locally advanced and borderline resectable pancreatic cancer and is curre…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer [Phase 2]
An exploratory Phase 2 clinical trial evaluating HRS-4642 in combination with immunotherapy and chemotherapy for pancreatic cancer, currentl…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer
A clinical trial update evaluating the feasibility of a novel neoantigen-reactive CD8+ T cell (NART) detection technology for postoperative …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Determining Individualized Cancer Therapy in Pancreatic Cancer
A clinical trial is investigating individualized cancer therapy for pancreatic cancer, with recruitment currently ongoing.
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
A clinical trial is evaluating a Raman spectroscopy-based deep learning model for early cancer diagnosis; recruitment is ongoing. The study …
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Stereotactic PAncreatic RadioTherapy Adjuvant Therapy [NA]
This clinical trial update reports a sponsored study by Istituto Clinico Humanitas evaluating stereotactic pancreatic radiotherapy as adjuva…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Multimodal Therapy Impact on Pancreatic Cancer Survival
This clinical trial update discusses a multimodal therapy approach for pancreatic cancer, incorporating neoadjuvant chemotherapy and pancrea…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: 18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
A clinical trial evaluating an 18F-labeled FAP-targeted molecular imaging probe for early tumor diagnosis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Compliance With ERAS Protocol in Pancreatic Surgery, Stress Response and Outcomes
A clinical trial evaluating adherence to Enhanced Recovery After Surgery (ERAS) protocols in pancreatic surgery and their effects on stress …
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Wet Heparinized Suction for Abdominal Cancer [NA]
This clinical trial update describes an investigative study of wet heparinized suction for abdominal cancers, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial evaluating nimotuzumab with irreversible electroporation ablation for locally advanced pancreatic cancer; the study…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: An Ultrasound Imaging Technique to Measure Tumors in People With Pancreatic Ductal Adenocarcinoma (PDAC) or Gastrointestinal (GI) Adenocarcinoma [NA]
Clinical trial update describing an ultrasound imaging technique to measure tumors in people with pancreatic ductal adenocarcinoma or gastro…
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Effect of an Enhanced Recovery After Surgery Program on Outcomes After Pancreatoduodenectomy
A clinical trial evaluating whether an Enhanced Recovery After Surgery program improves outcomes after pancreatoduodenectomy is currently re…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: A PhaseⅠStudy of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer [Phase 1]
Phase 1 clinical trial evaluating ONO-7475 in combination with ONO-4538 and gemcitabine plus nab-paclitaxel (GnP) and ONO-7475 with GnP for …
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer [Phase 1]
This is a Phase 1 clinical trial evaluating the combination of trametinib and hydroxychloroquine for pancreatic cancer; the study is current…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Hydroxychloroquine and Chlorphenesin Carbamate in Combination With mFOLFIRINOX in Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial is evaluating the safety and tolerability of combining hydroxychloroquine and chlorphenesin carbamate with the mFOL…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer
The document discusses the significance and indications for surgery in pancreatic cancer with synchronous liver metastases, in the context o…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Correlation Between Complications After Pancreaticoduodenectomy and Microbiota [NA]
A completed study evaluating the relationship between gut microbiota and complications after pancreaticoduodenectomy in pancreatic cancer pa…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1 [Phase 1]
This clinical trial update describes a Phase 1 study to compare the pharmacokinetics and safety of BR2021 versus BR2021-1 in patients with m…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating CHT102 for MSLN-positive advanced pancreatic cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Progressive Muscle Relaxation Exercises on Sleep, Fatigue and Pain in Pancreatic and Colon Cancer Patients [NA]
A clinical trial update notes a study evaluating progressive muscle relaxation to improve sleep, fatigue, and pain in pancreatic cancer and …
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update exploring adebrelimab in combination with the AG regimen (nab-paclitaxel + gemcitabine) for unresectable local…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER) [Phase 1]
Phase 1 clinical trial SHAPER investigates losartan with hypofractionated radiotherapy after chemotherapy for Borderline Resectable or Local…